Form 4: REGENXBIO Director Jean Bennett Reports Acquisition of Shares and Stock Options

Director Jean Bennett reported the acquisition of common stock and stock options in REGENXBIO Inc. on May 31, 2024.

Summary

• On May 31, 2024, Jean Bennett, a director of REGENXBIO Inc., reported acquiring 4,790 shares of common stock underlying a time-based restricted stock unit award (RSU).
• These shares will vest on May 1, 2025, contingent upon continuous service to the Issuer.
• Bennett also acquired 24,454 stock options with an exercise price of $14.35, vesting in 12 equal monthly installments starting May 31, 2024, also subject to continuous service.
• Following these transactions, Bennett directly owns 11,286 shares of common stock and 24,454 stock options.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock and option acquisitions by a company director. It doesn't inherently indicate positive or negative performance, but rather provides transparency.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.

Key Dates